Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Net Asset Momentum
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) recorded a net asset momentum of 2.1% as of December 2024, with net assets of CN¥1.36 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 301281 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Shandong Keyuan Pharmaceutical Co. Ltd. A Net Asset Momentum (2021–2024)
This chart tracks Shandong Keyuan Pharmaceutical Co. Ltd. A's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +2.1%, with net assets of CN¥1.36 Billion CNY as of December 2024. For live market cap and overall valuation, see Shandong Keyuan Pharmaceutical Co. Ltd. stock valuation.
Annual Net Asset History for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
The table below shows the complete annual net asset history for Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Shandong Keyuan Pharmaceutical Co. Ltd. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.36 Billion | CN¥1.55 Billion | CN¥192.87 Million | ▲ +2.1% |
| 2023 | CN¥1.33 Billion | CN¥1.47 Billion | CN¥138.93 Million | ▲ +156.1% |
| 2022 | CN¥519.73 Million | CN¥651.79 Million | CN¥132.06 Million | ▲ +20.6% |
| 2021 | CN¥430.98 Million | CN¥559.51 Million | CN¥128.52 Million | — |